Commercial Insight: Select Herpes Viruses And Human Papilloma Virus - Non-biologic Interventions

By Author: Manjula Menon
Total Articles: 1486
Comment this article

Despite high unmet need, the market for the small molecules used to manage conditions such as genital and oral herpes, genital warts, cytomegalovirus retinitis and pneumonia or shingles has been neglected compared with the successfully promoted immunizations for varicella in children, zoster in adults, or human papilloma virus in adolescents.

Scope of this report
Market overview of available treatments for four viral pathogens
Assessment of brand dynamics for major players
Comparative assessment of strengths and weaknesses in current and future competitive environment
Ten year sales volume and value forecast for the 7 Major Markets by brand, molecule and region
Research and analysis highlights
Current formulary reimbursement restrictions on valaciclovir could be overturned if generic rivals to Valtrex were launched at a dramatic discount rather than the commonly applied practice of charging highest achievable price , replacing acyclovir as the most popular drug in the process.

The level of unmet need in all four disease markets is still substantial, opening up substantial ...
... opportunities for true innovations in an otherwise highly genericised competitive environment characterized by high volume, low value offerings. The few existing late-stage development pipeline compounds will not be able to benefit.

While the seven Major Markets currently dominate the commercial landscape, the ROW offers huge scope for market expansion. While pricing levels are far lower, commodity products such as antivirals and antibacterials are an ideal platform for branded Pharma to increase their presence in Emerging Markets.

Key reasons to read this report
Identify key opportunities and threats that will impact the use and uptake of branded and generic products
Select effective lifecycle management strategies through analysis of key brand strategies
Understand and capitalize on clinical unmet needs in the market, either through lifecycle management of marketed drugs or new product development

For more information Kindly visit the website : http://www.bharatbook.com/detail.asp?id=83038

Or Contact us on :
Tel No : (+9122 )27578668 , 27579438
Fax: (+9122 )27579131

Address :
Bharat Book Bureau,
207,Hermes Atrium,
Sector-11
P.O Box 54,
CBD Belapur,
Navi Mumbai - 400614.

Bharat Book Bureau is the leading market research information aggregator which provides reports, company profiles, newsletters, country info. and online databases for the past twenty years to corporate, consulting firms, academic institutions, government departments, agencies etc., globally, including India. Bharat Book Bureau provides strategic information tools to the executives, business analysts, and knowledge managers that will help them to probe into and support critical, timely business decisions and strategies intelligence information requirements.